_version_ 1782221400223776768
author Kim, Seok Jin
author_facet Kim, Seok Jin
author_sort Kim, Seok Jin
collection PubMed
description
format Online
Article
Text
id pubmed-3259510
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-32595102012-01-18 Lymphoma stem cells: A step toward a new therapeutic target Kim, Seok Jin Korean J Hematol Perspective Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011-12 2011-12-27 /pmc/articles/PMC3259510/ /pubmed/22259624 http://dx.doi.org/10.5045/kjh.2011.46.4.211 Text en © 2011 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Perspective
Kim, Seok Jin
Lymphoma stem cells: A step toward a new therapeutic target
title Lymphoma stem cells: A step toward a new therapeutic target
title_full Lymphoma stem cells: A step toward a new therapeutic target
title_fullStr Lymphoma stem cells: A step toward a new therapeutic target
title_full_unstemmed Lymphoma stem cells: A step toward a new therapeutic target
title_short Lymphoma stem cells: A step toward a new therapeutic target
title_sort lymphoma stem cells: a step toward a new therapeutic target
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259510/
https://www.ncbi.nlm.nih.gov/pubmed/22259624
http://dx.doi.org/10.5045/kjh.2011.46.4.211
work_keys_str_mv AT kimseokjin lymphomastemcellsasteptowardanewtherapeutictarget